Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
formulary exclusions
Pharma
Cigna dangles $500 to patients who switch to Lilly's Taltz
A $500 offer to patients who switch from Novartis' Cosentyx to Lilly's Taltz could be a preview of 2023, when AbbVie's Humira faces biosimilar rivals.
Arlene Weintraub
Apr 6, 2021 10:55am
Biogen, Teva benefit as payers ease up on MS meddling: analyst
Aug 30, 2018 12:25pm
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead
Aug 7, 2018 12:29pm
